| NCT03364660 | Task-specific Epidural Stimulation Study | University of Louisville | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 2 years
- NOT have ability to move legs or stand on own
| Recruiting | 36 | NA | Technology | General health | | | 08 November 2017 | 06 December 2017 | 1 | |
| NCT03345576 | Testosterone and Long Pulse Stimulation After SCI | VA Office of Research and Development | | - Age 18 - 70 yrs
- Level T10-S5
AIS A, B- ≥ 0 hours
| Ended | 12 | PHASE2 | Drug | Standing/walking/mobility | | | 01 July 2018 | 17 November 2017 | 1 | |
| NCT03267810 | TENS Trial to Prevent Neuropathic Pain in SCI | University of Miami | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≤ 4 months
| Ended | 31 | NA | Technology | Pain | | | 14 August 2017 | 30 August 2017 | 1 | |
| NCT03292315 | Once Weekly GLP-1 in Persons With Spinal Cord Injury | James J. Peters Veterans Affairs Medical Center | | - Age 18 - 69 yrs
- Level C1-S5
AIS D- 3 months - 69 years
| Ended | 5 | PHASE4 | Drug | General health | | | 16 October 2018 | 25 September 2017 | 1 | |
| NCT03229031 | A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury | Eusol Biotech Co., Ltd. | | - Age 18 - 65 yrs
- Level C1-S5
AIS A- ≤ 65 years
| Ended | 160 | PHASE3 | Drug | Standing/walking/mobility | | | 07 March 2018 | 25 July 2017 | 4 | |
| NCT03225625 | Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study | MD Stem Cells | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≤ 0 hours
| By invitation | 40 | NA | Biological/cell based | General health | | | 01 July 2017 | 21 July 2017 | 2 | |
